Replies to post #139595 on Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

Three times weekly dosing for Kevetrin Phase II Ovarian trial is great news. I'd worried that they might limit it to two. Very glad to see three times weekly. ;)

The FDA must like the data shown to them that was collected earlier in support of the Ovarian cancer trial. Final trial data wasn't available at the time of submission.

Nasdaq link: http://www.nasdaq.com/press-release/cellceutix-meets-with-fda-for-phase-2-clinical-trial-of-kevetrin-for-ovarian-cancer-20160210-00881




In Reply to 'Golfguru03'
I agree Zport...the FDA has approved 3 times a week dosing to combat Ovarian Cancer and most likely any other Phase II trials coming soon...like Pancreatic Cancer...both receiving Orphan Drug Status...

Mark